Why the Newest Psychiatric Diagnostic Bible Will Be a Boon for Big Pharma
The DSM-5 will likely lead patients down a road of over-diagnosis and over-medication.February 8, 2013 |
After the American Psychiatric Association (APA) approved the latest version of its diagnostic bible, the DSM-5, psychiatrist Allen Frances, the former chair of the DSM-4 task force and currently professor emeritus at Duke, announced, “This is the saddest moment in my 45-year career of practicing, studying and teaching psychiatry” (“ A Tense Compromise on Defining Disorders”).
The DSM-5 (the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders) will be released by the APA in spring 2013.
However, Frances states, “My best advice to clinicians, to the press, and to the general public—be skeptical and don't follow DSM-5 blindly down a road likely to lead to massive over-diagnosis and harmful over-medication.”
http://www.alternet.org/personal-health/why-newest-psychiatric-diagnostic-bible-will-be-boon-big-pharma?akid=10038.236099.t_wgdN&rd=1&src=newsletter792106&t=9
Login
Register
FAQ
Search
